TirzepaTide Lynophilizes Usukuye 99% Ifu ya Tr 10MG 15MG 20MG 30MG kuri buri ngaruka kuri vial isukari

Tirzepatde ni umwihariko wa glucosse-kwishingikiriza insulinetropic polypropdide / glcagon-nka peptide 1 (glp-1) kunoza ingwate kumubiri hamwe na diyabete yo mu bwoko bwa 2 kandi iperereza kugirango rikoreshwe Gucunga ibiro bidakwiye, imibiririzi majorse yamashanyarazi no gucunga ibindi bintu, harimo no kunanirwa n'umutima hamwe nimibanire yazigamye hamwe nubwitonzi hamwe nabadafite inkoni. Icyiciro cya 3 kirenze gahunda yo kugerageza 1-5 zagenewe gusuzuma imikorere n'umutekano wa kabiri-byashizwe mu gitondo (5, 10 na 15 mg), kuvura monotherapi cyangwa imivugo, hakurya ya diyabete nini. Gukoresha Tirzepateri Mubumenyi bwubuvuzi bwahujwe no kugabanuka kugaragara kwa hemoglobine (-1.87 kugeza -2.59%, -20 MMOL / MOL), hamwe no kugabanya ibipimo mubisanzwe bifitanye isano no kurwara cardiometabolic, nkumuvuduko wamaraso, imyambarire ya viscerale no gukwirakwiza triglyceside. TirzepaTde yari yihanganiye neza, afite ibyago bike byo kurya hypoglycaemia iyo bikoreshejwe nta ibyuma bya insuline cyangwa insuline kandi byerekanaga umwirondoro wa GLP-1 Scaptar. Kubera iyo mpamvu, ibimenyetso bivuye muri ibyo bigeragezo by'amavuriro byerekana ko Tirzepatde itanga amahirwe mashya yo kugabanya neza amarushanwa meza ya hemoglobine n'umubiri mubantu bakuru hamwe na diyabete yo mu bwoko bwa 2.